Monopar Therapeutics (MNPR) Misses Q1 EPS by 46c

Monopar Therapeutics (NASDAQ: MNPR) reported Q1 EPS of ($0.46).

For earnings history and earnings-related data on Monopar Therapeutics (MNPR) click here.

You May Also Be Interested In

• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Travel + Leisure (TNL) Reiterated at Buy by Stifel: 'There is Upside to the Multiple'
• McCormick & Company (MKC) Reiterated at Hold by Stifel After 'Strong Than Expected' Q2